A Phase II study evaluating intermittent letrozole as adjuvant endocrine therapy for postmenopausal women with hormone-receptor positive, early stage breast cancer.
Phase of Trial: Phase II
Latest Information Update: 24 Mar 2012
At a glance
- Drugs Letrozole (Primary)
- Indications Early breast cancer
- Focus Biomarker; Therapeutic Use
- 11 Jul 2011 New trial record